Affordability was raised in particular regarding CGM, which is available through the NHS for all adults with type 1 diabetes and for some adults with type 2 diabetes (eg, if insulin-treated or other clinical need is identified) [28]. This evidence concerns the gene INS and type 1 diabetes mellitus.